IN001

· Shenzhen Shenxin Biotechnology Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IN001, covering 2026-03-31 to 2026-03-31. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants [Phase 1]

See pricing